We Help Companies Find New Sales Opportunities
Oxford Molecular has sold its software division to Pharmacopeia of the US for £18m, and the remaining business will now be liquidated.
Oxford Molecular is selling Cambridge Discovery Chemistry to Millennium Pharmaceuticals for £35m, in order to reduce debt.
Oxford Molecular is set to acquire Chemical Design Holdings, the pharmaceutical software company, for about £6m.
Oxford Molecular is acquiring Genetics Computer and MRL Automation, two US software companies that specialise in the development of new drugs, funded by a £30m rights issue.
Oxford Molecular, the developer of software for the drugs industry, has bought three US companies - Chemical Informatics, MacVector and Health Designs.